Reading: Oracle slips 1.44% even as Wall Street closes higher ahead of June 10 earnings

Oracle slips 1.44% even as Wall Street closes higher ahead of June 10 earnings

Published
3 min read
Advertisement

fell 1.44% to $244.58 in the latest trading session, a rare slide on a day when the major U.S. indexes all moved higher. The gained 0.13%, the Dow rose 0.45% and the added 0.03%, leaving Oracle behind the broader market even after a strong month.

The drop mattered because the stock had climbed 37.64% over the past month, so Thursday’s move stood out more than the percentage alone would suggest. Investors watching Oracle now have a date to circle: the company is scheduled to report earnings on June 10, 2026, and the numbers being modeled into that release point to another quarter of growth.

Oracle is projected to post earnings of $1.96 per share, up 15.29% from a year earlier, on revenue of $19.09 billion, which would be 20.03% above the prior-year quarter. That topline estimate lands alongside a full-year outlook calling for earnings of $7.46 per share and revenue of $67.22 billion, while the Consensus EPS estimate has slipped 0.01% over the last 30 days. The stock is also changing hands at a forward price-to-earnings ratio of 31.06, well above the 16.76 average for its industry, and carries a PEG ratio of 1.8 versus 1.69 for the Computer - Software group.

- Advertisement -

That valuation gap helps explain why the next report is drawing attention. Oracle is a software maker in the Computer and Technology sector, and its recent estimate revisions and price tag are being watched closely against an industry with a Zacks Industry Rank of 158, which places it in the bottom 36% of more than 250 industries. The company has already been the subject of investor scrutiny in other stories this year, from its stock rally to questions over data safeguards, but the near-term focus is now squarely on whether June 10 brings enough business momentum to justify the market’s expectations.

Oracle’s next update will answer that question quickly. If the company matches the current consensus, it will show growth that is still healthy, but it will also have to do so from a valuation that leaves little room for disappointment.

Advertisement
Share This Article